: Brazil suspends Covaxin’s import authorisation #IndiaNEWS Brazil has provisionally suspended its decision to grant temporary Emergency Use Authorisation to Bharat Biotech’s Covaxin for the import

@IndiaNEWS

Posted in: #IndiaNEWS

Brazil suspends Covaxin’s import authorisation #IndiaNEWS
Brazil has provisionally suspended its decision to grant temporary Emergency Use Authorisation to Bharat Biotech’s Covaxin for the import of 4 million, or 40 lakh, coronavirus vaccine doses, reported PTI on Thursday.In a statement on Tuesday, Brazilian healthcare regulator Anvisa said it shelved its decision after Bharat Biotech terminated its pact to sell the vaccine doses to Precisa Medicamentos and Envixia Pharmaceuticals, the biotechnology company’s intermediaries in Brazil.The decision came amid a federal investigation that is underway into alleged irregularities in a contract between Brazil’s health ministry and Bharat Biotech for 20 million – 2 crore – doses of Covaxin. The deal was made despite Covaxin’s failure to obtain regulatory clearance for the vaccine’s use in the country. The Brazilian government suspended its contract with Bharat Biotech on June 29.On June 4, the healthcare regulator had granted the temporary emergency use authorisation, but only allowed 40 lakh doses to be imported. The corruption allegations pertain to buying the Covaxin doses at a higher price. To buy vaccines, the Brazilian health ministry needed to pay 0 million (Rs 2,375 crore approximately) to Precisa Medicamentos. So each dose of Covaxin will cost Brazil (approximately Rs 1,100).This is significantly higher than what the health ministry paid for American pharmaceutical giant Pfizer’s vaccine, which...Read more

Intraday stocks under 50 NSE India Twitter of India

Vote Up Vote Down

Login to post a comment!